Pet Pharm Biotech Co., Ltd. (TPEX:7762)
Taiwan · Delayed Price · Currency is TWD 62.60
+0.80 (1.29%)
At close: Mar 6, 2026
Pet Pharm Biotech Market Cap
Pet Pharm Biotech has a market cap or net worth of 3.21 billion as of March 6, 2026. Its market cap has increased by 9.00% in one year.
Market Cap
3.21B
Enterprise Value
2.81B
Revenue
159.02M
Ranking
n/a
PE Ratio
152.73
Stock Price
62.60
Market Cap Chart
Since July 26, 2024, Pet Pharm Biotech's market cap has increased from 1.39B to 3.21B, an increase of 130.26%. That is a compound annual growth rate of 67.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 3.21B | -10.57% |
| Dec 31, 2025 | 3.58B | 116.51% |
| Dec 31, 2024 | 1.66B | 18.92% |
| Jul 26, 2024 | 1.39B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Richmond International Travel & Tours Co.,Ltd | 3.28B |
| Shine-On BioMedical | 3.28B |
| Jtron Technology | 3.28B |
| Ultra Chip | 3.27B |
| GrandTech Cloud Services | 3.24B |
| East Tender Optoelectronics | 3.23B |
| SunWay Biotech Co., LTD. | 3.22B |
| ABC Taiwan Electronics | 3.22B |